Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies
about
Phenothiazines inhibit S100A4 function by inducing protein oligomerizationStructure of Human Na+/H+ Exchanger NHE1 Regulatory Region in Complex with Calmodulin and Ca2+Insights into molecular interactions between CaM and its inhibitors from molecular dynamics simulations and experimental data.Characterisation of two calmodulin-like proteins from the liver fluke, Fasciola hepatica.Dissociation of calmodulin-target peptide complexes by the lipid mediator sphingosylphosphorylcholine: implications in calcium signaling.Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor.Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulinScreening calmodulin-binding ligands using intensity-fading matrix-assisted laser desorption/ionization mass spectrometry.Opposing orientations of the anti-psychotic drug trifluoperazine selected by alternate conformations of M144 in calmodulinEffects of 39 Compounds on Calmodulin-Regulated Adenylyl Cyclases AC1 and Bacillus anthracis Edema FactorStructure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifenNMR and molecular dynamics studies of the interaction of melatonin with calmodulin.Single-Molecule FRET States, Conformational Interchange, and Conformational Selection by Dye Labels in CalmodulinStructural and biophysical characterization of the interactions between the death domain of Fas receptor and calmodulin.Two-Dimensional NMR Lineshape Analysis.Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins.Trifluoperazine regulation of calmodulin binding to Fas: a computational study.Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.Exploring NMR ensembles of calcium binding proteins: perspectives to design inhibitors of protein-protein interactionsThe structure of the complex of calmodulin with KAR-2: a novel mode of binding explains the unique pharmacology of the drug.
P2860
Q27660911-DC9EDEA8-E587-41B8-AC25-BDAAE5655D2CQ27674259-371BCC3A-FF04-4B34-9B6D-3B054BA0BF35Q30897301-5E7A2B72-D1BE-47D1-806B-C21074473CC1Q33286931-D12BE660-3251-4D9C-BC94-C8118E4F4B42Q33581912-E119D1E1-1C7A-45B4-8F0F-29EC108BFC9AQ33953010-B6BAD50F-75FE-4E09-91ED-DAB211736A8EQ34032620-560C4FD1-D5A9-427B-9296-794F3A4B0D1BQ34748621-A4B2E44A-C3C7-40DB-B801-553FFAA60B40Q35450179-B9609041-7425-4267-A787-BC1022D596D8Q35623187-2070BB43-9AE3-4DF9-81F0-C51D3F4102D0Q35643319-BA7F2ECD-B88A-4948-B531-2C3A75378C2FQ36526298-1F9BEDA1-6D57-429B-800A-09997759694BQ36973513-2B425F9C-EF00-4D71-9A59-1CB587069AA5Q37048442-BF1182DF-9181-4855-B468-CABDD6E2F999Q39826299-1FE2C52F-50E4-4C15-862A-A144E43EBA88Q39894584-598B8CBC-D7A4-49B6-A2A6-1F05D0C6B822Q41850711-900865C1-6E33-4803-BCAB-353B7D284797Q42009235-052F3B87-AD52-423D-9E58-43B83FD2119AQ42760404-F9645577-38DE-4D8E-974C-69999E937B56Q45185616-423849F5-E835-48E6-952A-C4C8A0F93E2F
P2860
Simultaneous binding of drugs with different chemical structures to Ca2+-calmodulin: crystallographic and spectroscopic studies
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Simultaneous binding of drugs ...... phic and spectroscopic studies
@ast
Simultaneous binding of drugs ...... phic and spectroscopic studies
@en
Simultaneous binding of drugs ...... phic and spectroscopic studies
@nl
type
label
Simultaneous binding of drugs ...... phic and spectroscopic studies
@ast
Simultaneous binding of drugs ...... phic and spectroscopic studies
@en
Simultaneous binding of drugs ...... phic and spectroscopic studies
@nl
prefLabel
Simultaneous binding of drugs ...... phic and spectroscopic studies
@ast
Simultaneous binding of drugs ...... phic and spectroscopic studies
@en
Simultaneous binding of drugs ...... phic and spectroscopic studies
@nl
P2093
P3181
P356
P1433
P1476
Simultaneous binding of drugs ...... phic and spectroscopic studies
@en
P2093
P304
15300-15310
P3181
P356
10.1021/BI980795A
P407
P577
1998-11-01T00:00:00Z